(Q74346099)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997819%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997819%20AND%20SRC:MED&resulttype=core&format=json

carcinoma of unknown primary

10 November 2019

main subject

1 reference

1 reference

1 reference

F X Parnis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997819%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

I N Olver

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997819%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

D Kotasek

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997819%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J Norman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997819%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Taylor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997819%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J Russell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997819%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

K Patterson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997819%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

D Keefe

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997819%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

T Marafioti

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997819%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997819%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997819%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997819%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997819%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

883-884

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997819%20AND%20SRC:MED&resulttype=core&format=json

An analysis of 1539 patients with cancer of unknown primary site

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008311919633

7 January 2021

Treatment of patients with cancer of an unknown primary site

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008311919633

7 January 2021

Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008311919633

7 January 2021

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008311919633

7 January 2021

A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008311919633

7 January 2021

Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008311919633

7 January 2021

Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008311919633

7 January 2021

Identifiers

DOI

10.1023/A:1008311919633

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10997819%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference